Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma
- PMID: 23820107
- DOI: 10.1177/0194599813496373
Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma
Abstract
Objective: Second primary malignancies (SPMs) are common in patients with head and neck squamous cell carcinoma (HNSCC) and have a negative impact on their survival. This study aimed to evaluate risk factors for SPM occurrence and cause-specific mortality in Asian HNSCC patients.
Study design: A retrospective cohort study.
Setting: University teaching hospital.
Subjects: Nine hundred and thirty-seven patients without previous cancer history who were treated between 2000 and 2009 and followed for at least 2 years.
Methods: Confirmation of SPMs was performed by histopathology. The cumulative probability of a SPM among survivors of index HNSCC was calculated using a competing risk model. Univariate and multivariate analyses were utilized to determine factors predictive of SPM occurrence and cause-specific mortality.
Results: Of 937 patients, cumulative incidence of SPMs was 7.2% at 0 to 6 months (synchronous), 17.9% at 5 years, and 23.1% at 10 years after index tumor diagnosis. In multivariate analyses, old age (>60 years) (P = .002), hypopharyngeal index tumor site (P = .001), and heavy drinker (P = .001) were independently associated with the development of SPMs, and hypopharyngeal index tumor site were independent variables for SPM-specific survival (P < .001). Cumulative incidence function of SPM-specific mortality according to index tumor sites was significantly higher in the hypopharynx than other sites (P = .011).
Conclusion: Elderly patients, hypopharyngeal index cancer patients, or heavy drinkers may require careful surveillance for the development of SPMs. Our results may help identify and properly manage Asian patients at high risk of SPMs.
Keywords: cumulative incidence; head and neck squamous cell carcinoma; risk factor; second primary malignancy; survival.
Similar articles
-
Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19. Cancer. 2013. PMID: 23423883
-
Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.Acta Otolaryngol. 2007 Jun;127(6):651-7. doi: 10.1080/00016480600951517. Acta Otolaryngol. 2007. PMID: 17503236
-
Second primary lung malignancy following head and neck squamous cell carcinoma.Laryngoscope. 2019 Apr;129(4):903-909. doi: 10.1002/lary.27422. Epub 2018 Nov 22. Laryngoscope. 2019. PMID: 30565703
-
Synchronous and metachronous head and neck carcinomas.Cancer. 1994 Oct 1;74(7):1933-8. doi: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. Cancer. 1994. PMID: 8082099 Review.
-
Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.Indian J Pathol Microbiol. 2021 Oct-Dec;64(4):725-731. doi: 10.4103/IJPM.IJPM_1055_20. Indian J Pathol Microbiol. 2021. PMID: 34673592 Review.
Cited by
-
DeintensiF: Standard versus individualized deintensified follow-up after curative treatment in head and neck cancer: protocol of a randomized pilot study.Pilot Feasibility Stud. 2025 May 16;11(1):69. doi: 10.1186/s40814-025-01651-3. Pilot Feasibility Stud. 2025. PMID: 40380278 Free PMC article.
-
Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.Support Care Cancer. 2019 Jul;27(7):2609-2616. doi: 10.1007/s00520-018-4559-5. Epub 2018 Nov 22. Support Care Cancer. 2019. PMID: 30467794
-
Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity.Rep Pract Oncol Radiother. 2017 Jul-Aug;22(4):331-339. doi: 10.1016/j.rpor.2017.05.001. Epub 2017 Jun 7. Rep Pract Oncol Radiother. 2017. PMID: 28663716 Free PMC article.
-
Head and neck cancer survivorship consensus statement from the American Head and Neck Society.Laryngoscope Investig Otolaryngol. 2021 Nov 30;7(1):70-92. doi: 10.1002/lio2.702. eCollection 2022 Feb. Laryngoscope Investig Otolaryngol. 2021. PMID: 35155786 Free PMC article. Review.
-
Longitudinal Assessment of the Quality of Life in Oral Squamous Cell Carcinoma Patients.Cureus. 2024 May 19;16(5):e60596. doi: 10.7759/cureus.60596. eCollection 2024 May. Cureus. 2024. PMID: 38894763 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical